[Mortality among drug addicts: an Italian multicenter study. ESEDA group (Epidemiological Studies on Effects of Drug Abuse)]

Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

[Mortality among drug addicts: an Italian multicenter study. ESEDA group (Epidemiological Studies on Effects of Drug Abuse)]

Epidemiol Prev. 1997 Oct-Dec;21(4):265-71. Unique Identifier : AIDSLINE MED/98150486

Abstract: To investigate temporal and geographical differences in mortality of intravenous drug users (IDUs) in Italy, a multicenter cohort of IDUs entering public treatment centres in Turin (n = 6975), Rome (n = 4660), Naples (n = 3785) and Cagliari (n = 1630) between 1980-1992, was enrolled and followed up till the end of 1992. High mortality rates for all causes, ranging between 20.5/1000 person-years in Rome and 11.0/1000 in Naples, were observed especially in the last two years of the follow-up except in Naples where the mortality reached a maximum in 1983-84. The major causes of death were overdose, AIDS and violence but with some differences among centres. In all cities, the observed mortality among drug injectors was greater than that of the general population; SMRs for all causes were 15.1 (CL = 13.9-16.4) in Turin, 15.6 (CL = 14.4-16.8) in Rome, 8.2 (CL = 7.1-9.5) in Naples and 11.9 (LC = 10.2-13.7) in Cagliari. Different selection criteria for entering treatment throughout centres, and the heterogeneity of the therapeutic programmes offered can be considered to explain the differences of mortality observed among drug users. With regard to the heterogeneity in overdose mortality, the geographical and temporal variations in illegal drugs market should be taken into account. Further investigations are needed to verify these hypotheses.

Keywords: *Substance Abuse, Intravenous/MORTALITY
980630
M9861766

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .